REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 79 filers reported holding REPLIMUNE GROUP INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,465,703 | -18.0% | 1,430,025 | +11.3% | 0.01% | -20.0% |
| Q2 2023 | $29,824,541 | +56.9% | 1,284,449 | +19.3% | 0.01% | +66.7% |
| Q1 2023 | $19,010,269 | +96178.9% | 1,076,483 | +48.3% | 0.01% | 0.0% |
| Q4 2022 | $19,745 | -99.8% | 725,888 | +12.1% | 0.01% | +50.0% |
| Q3 2022 | $11,178,000 | +35.2% | 647,356 | +36.8% | 0.00% | +33.3% |
| Q2 2022 | $8,269,000 | +41.4% | 473,056 | +37.4% | 0.00% | +50.0% |
| Q1 2022 | $5,848,000 | -7.2% | 344,397 | +48.1% | 0.00% | 0.0% |
| Q4 2021 | $6,301,000 | +21.2% | 232,477 | +32.6% | 0.00% | 0.0% |
| Q3 2021 | $5,198,000 | +100.2% | 175,360 | +159.6% | 0.00% | +100.0% |
| Q2 2021 | $2,596,000 | +155.0% | 67,552 | +102.8% | 0.00% | – |
| Q1 2021 | $1,018,000 | -19.1% | 33,310 | +1.4% | 0.00% | – |
| Q4 2020 | $1,258,000 | +66.2% | 32,856 | 0.0% | 0.00% | – |
| Q3 2020 | $757,000 | +138.8% | 32,856 | +157.6% | 0.00% | – |
| Q2 2020 | $317,000 | – | 12,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |